Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbamazepine drug interactions.

A M Baciewicz

    Therapeutic Drug Monitoring
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Carbamazepine (CBZ) can alter the metabolism of many medications, potentially leading to significant drug interactions. Other drugs can also affect how CBZ is metabolized, requiring careful consideration during treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bleeding associated with doxycycline and warfarin treatment.

    Archives of internal medicine·2001
    Same author

    Acute pancreatitis associated with celecoxib.

    Annals of internal medicine·2000
    Same author

    Isoniazid drug and food interactions.

    The American journal of the medical sciences·1999
    Same author

    Update on rifampin drug interactions, III.

    Archives of internal medicine·1997
    Same author

    Cholestasis: hepatocellular reaction to trimethoprim/sulfamethoxazole.

    The Annals of pharmacotherapy·1994
    Same author

    Quality and productivity assessment of clinical pharmacy interventions.

    Hospital formulary·1994
    Same journal

    A Novel Dosing Strategy for Tacrolimus in Lung Transplant Recipients: Integrating Machine Learning with Population Pharmacokinetic Analysis.

    Therapeutic drug monitoring·2026
    Same journal

    Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

    Therapeutic drug monitoring·2026
    Same journal

    Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

    Therapeutic drug monitoring·2026
    Same journal

    Deltamethrin Placental Transfer and Seasonal Pyrethroid Exposure: A Mother-Newborn Dyad Pilot Study.

    Therapeutic drug monitoring·2026
    Same journal

    A Clustering-Based Grey Modeling Approach for Tacrolimus Concentration Prediction Under Sparse Therapeutic Drug Monitoring.

    Therapeutic drug monitoring·2026
    Same journal

    Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements".

    Therapeutic drug monitoring·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Drug Metabolism
    • Clinical Pharmacy

    Background:

    • Carbamazepine (CBZ) is a widely used anticonvulsant and treatment for trigeminal neuralgia.
    • CBZ is known to interact with other drugs due to its effects on hepatic metabolism.
    • Understanding these interactions is crucial for patient safety and effective pharmacotherapy.

    Purpose of the Study:

    • To review the known drug interactions involving Carbamazepine (CBZ).
    • To highlight how CBZ affects the metabolism of other drugs and vice versa.
    • To emphasize the clinical significance of these drug interactions.

    Main Methods:

    • Literature review of studies and case reports on Carbamazepine (CBZ) drug interactions.
    • Analysis of documented instances of CBZ inducing or inhibiting drug metabolism.

    Related Experiment Videos

  • Examination of how other drugs affect CBZ metabolism.

    • Main Results:

    • CBZ accelerates the metabolism of phenytoin, phenobarbital (PB), primidone, valproic acid, and warfarin.
    • Phenytoin, PB, and primidone can increase the hepatic metabolism of CBZ.
    • Inhibitors of CBZ metabolism include triacetyloleandomycin, erythromycin, propoxyphene, isoniazid, and cimetidine.

    Conclusions:

    • Clinically significant drug interactions involving Carbamazepine (CBZ) are common.
    • Both induction and inhibition of CBZ metabolism by other drugs occur.
    • Further research is needed to fully elucidate the clinical impact and identify new interactions.